血友病是否增加全髋与全膝关节置换术后不良结局风险?一项全国人群研究的倾向评分匹配分析
基于台湾全民健康保险研究数据库的回顾性队列研究,纳入121例血友病患者与194,026例非血友病患者,按1:4倾向评分匹配后分析全髋与全膝关节置换术后结局。血友病患者术后输血风险、住院时间及住院费用均更高,全髋置换组1年感染率8.11% vs 3.38%(P=0.206)但未达统计学显著,其他并发症与死亡率无差异。
要点
- 血友病患者全髋置换术后输血调整风险比为5.262(95%CI 3.044-26.565,P<.001)。
- 血友病患者全膝置换术后输血调整风险比为6.279(95%CI 3.246-28.903,P<.001)。
- 血友病患者住院时间更长、住院总费用更高,其他并发症与死亡率无差异。
核心结论
- 血友病患者全髋与全膝置换术后输血率、住院费用及住院时间均更高。
- 全髋置换术后1年感染率存在值得注意的临床差异,但分析受小样本量限制。
- 其他术后并发症与死亡率两组相当。
- 应告知血友病患者全髋置换术后感染率可能高达8%。
- 需进一步研究以制定预防性和有效的方法,降低血友病患者全髋与全膝置换术的输血率及相关不良结局。
研究设计与样本
- 回顾性队列研究,使用全民健康保险研究数据库数据。
- 识别2000年至2015年间接受全髋与全膝关节置换的血友病患者。
- 共纳入121例血友病患者与194,026例非血友病患者。
- 通过倾向评分匹配按1:4比例将血友病患者与非血友病患者匹配。
- 采用多变量回归分析控制混杂变量,比较术后并发症与死亡风险、住院时间差异及住院费用。
主要发现
- 倾向评分匹配及多变量回归分析后,全髋置换组血友病患者术后输血的调整风险比为5.262(95%CI 3.044-26.565,P<.001),全膝置换组为6.279(95%CI 3.246-28.903,P<.001),均与对照组比较。
- 血友病患者住院时间更长(全髋组95%CI 1.541-2.669,P<.001;全膝组95%CI 1.568-2.786,P<.001)。
- 血友病患者住院总费用更高(全髋组95%CI 3.518-8.293,P<.001;全膝组95%CI 3.584-8.842,P<.001)。
- 全髋置换组血友病患者1年感染率更高但未达统计学显著(8.11% vs 3.38%,P=.206)。
- 血友病与非血友病组间30天和90天并发症率、1年感染率、再手术率及死亡率无差异。
关键数值与推荐
- 全髋置换组术后输血调整风险比5.262(95%CI 3.044-26.565,P<.001)。
- 全膝置换组术后输血调整风险比6.279(95%CI 3.246-28.903,P<.001)。
- 全髋置换组1年感染率8.11% vs 3.38%(P=.206),未达统计学显著。
临床怎么用
- 作者认为应告知血友病患者全髋置换术后感染率可能高达8%。
- 作者指出需进一步研究以制定预防性和有效的方法,降低血友病患者全髋与全膝置换术的输血率及相关不良结局。
局限性
- 原文指出分析受小样本量限制。
- 原文结论提出需进一步研究以制定预防性和有效的方法,降低血友病患者全髋与全膝置换术的输血率及相关不良结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: End-stage hemophilic arthropathy is the result of recurrent joint hemarthrosis. Although total hip arthroplasty (THA) and total knee arthroplasty (TKA) can reduce severe joint pain and improve functional activity, controversy remains regarding outcomes after THA and TKA among patients with hemophilia. This study evaluated the risk of adverse outcomes of hemophilia patients who underwent THA and TKA. METHODS: This retrospective cohort study was conducted using data from the National Health Insurance Research Database. Patients who had hemophilia and underwent THA and TKA between 2000 and 2015 were identified. A total of 121 patients with hemophilia and 194,026 patients without hemophilia were included. Through propensity score matching, patients with hemophilia were matched at a 1:4 ratio to patients without hemophilia. Multivariable regression analysis was used to control for confounding variables and compare the risk of postoperative complications and mortality, differences in length of stay, and cost of care for the hospital. RESULTS: After propensity score matching and multivariate regression analysis, the adjusted hazard ratio of postoperative transfusion for hemophilia patients was 5.262 (95% confidence interval [CI] = 3.044-26.565, P < .001) in THA group and 6.279 (95% CI = 3.246-28.903, P < .001) in TKA group, when compared with the control group. Patients with hemophilia had longer length of hospital stay (THA group: 95% CI, 1.541-2.669, P < .001; TKA group: 95% CI, 1.568-2.786; P < .001) and higher total hospital charges (THA group: 95% CI, 3.518-8.293, P < .001; TKA group: 95% CI, 3.584-8.842; P < .001) compared to patients without hemophilia. Hemophiliacs had a higher yet nonsignificant 1-year infection rate (8.11% vs 3.38%, P = .206) in the THA group. There were no differences between the rates of 30-day and 90-day complications, 1-year infection, reoperation and mortality between the hemophilia and nonhemophilia groups. CONCLUSION: Hemophilia patients have higher rates of postoperative transfusion, hospital costs, and increased length of stay. There is an appreciable clinical difference in 1-year infection rates following THA but our analysis was limited by the small sample size. Other postoperative complications and mortality rates were comparable. Patients with hemophilia should be counseled that infection rate maybe as high as 8% following THA. Further investigation is needed to develop prophylactic and effective methods to decrease the rates of transfusions and associated adverse outcomes in hemophilia patients undergoing THA and TKA.
引用
- Wang SH, Chung CH, Chen YC, et al. Does Hemophilia Increase Risk of Adverse Outcomes Following Total Hip and Knee Arthroplasty? A Propensity Score-Matched Analysis of a Nationwide, Population-Based Study. J Arthroplasty. 2019. PMID: 31337553. doi:10.1016/j.arth.2019.05.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。